Literature DB >> 31646884

α-synuclein accumulation in SH-SY5Y cell impairs autophagy in microglia by exosomes overloading miR-19a-3p.

Tianen Zhou1, Danyu Lin2, Ying Chen3, Sudan Peng3, Xiuna Jing3, Ming Lei3, Enxiang Tao3, Yanran Liang3.   

Abstract

Aims: To reveal whether miRNAs in exosomes from α-synuclein transgenic SH-SY5Y cells are able to regulate autophagy in recipient microglia. Materials & methods: Microarray analysis and experimental verification were adopted to assess the significance of autophagy-associated miRNAs in exosomes from neuronal model of α-synucleinopathies.
Results: We found that miR-19a-3p increased remarkably in the exosomes from α-synuclein gene transgenic SH-SY5Y cells. Further study inferred that α-synuclein gene transgenic SH-SY5Y cell-derived exosomes and miR-19a-3p mimic consistently inhibited the expression of phosphatase and tensin homolog and increased the phosphorylation of AKT and mTOR, both of which ultimately lead to the dysfunction of autophagy in recipient microglia.
Conclusion: The data suggested that enhanced expression of miR-19a-3p in exosomes suppress autophagy in recipient microglia by targeting the phosphatase and tensin homolog/AKT/mTOR signaling pathway.

Entities:  

Keywords:  AKT; PTEN; Parkinson's disease; SH-SY5Y cell; autophagy; exosome; mTOR; miR-19a-3p; microglia; α-synuclein

Mesh:

Substances:

Year:  2019        PMID: 31646884     DOI: 10.2217/epi-2019-0222

Source DB:  PubMed          Journal:  Epigenomics        ISSN: 1750-192X            Impact factor:   4.778


  11 in total

Review 1.  Autophagy and apoptosis cascade: which is more prominent in neuronal death?

Authors:  Rohan Gupta; Rashmi K Ambasta
Journal:  Cell Mol Life Sci       Date:  2021-11-06       Impact factor: 9.261

Review 2.  The Emerging Role of the Interaction of Extracellular Vesicle and Autophagy-Novel Insights into Neurological Disorders.

Authors:  Wei Wei; Yongli Pan; Xinyu Yang; Zhonglun Chen; Yue Heng; Bufan Yang; Mingjun Pu; Jiacai Zuo; Zhuhong Lai; Yufeng Tang; Wenqiang Xin
Journal:  J Inflamm Res       Date:  2022-06-09

Review 3.  The Messenger Apps of the cell: Extracellular Vesicles as Regulatory Messengers of Microglial Function in the CNS.

Authors:  Adeyemi A Olanrewaju; Ramin M Hakami
Journal:  J Neuroimmune Pharmacol       Date:  2020-04-27       Impact factor: 4.147

Review 4.  Autophagy and Exosomes Relationship in Cancer: Friends or Foes?

Authors:  Marta Colletti; Donatella Ceglie; Angela Di Giannatale; Francesca Nazio
Journal:  Front Cell Dev Biol       Date:  2021-01-12

Review 5.  Crosstalk between exosomes and autophagy: A review of molecular mechanisms and therapies.

Authors:  Huifang Xing; Jin Tan; Yuyang Miao; Yingmei Lv; Qiang Zhang
Journal:  J Cell Mol Med       Date:  2021-01-27       Impact factor: 5.310

Review 6.  Role of exosomes in the pathogenesis of inflammation in Parkinson's disease.

Authors:  Ke-Lu Li; Hong-Yan Huang; Hui Ren; Xing-Long Yang
Journal:  Neural Regen Res       Date:  2022-09       Impact factor: 5.135

Review 7.  Mitochondrial Dysfunction in Parkinson's Disease: From Mechanistic Insights to Therapy.

Authors:  Xiao-Yan Gao; Tuo Yang; Ying Gu; Xiao-Hong Sun
Journal:  Front Aging Neurosci       Date:  2022-06-20       Impact factor: 5.702

8.  Alpha-synucleinopathy reduces NMNAT3 protein levels and neurite formation that can be rescued by targeting the NAD+ pathway.

Authors:  Richard B Parsons; Altin Kocinaj; Gustavo Ruiz Pulido; Sarah A Prendergast; Anna E Parsons; Paul D Facey; Frank Hirth
Journal:  Hum Mol Genet       Date:  2022-08-25       Impact factor: 5.121

Review 9.  Non-Coding RNAs in the Brain-Heart Axis: The Case of Parkinson's Disease.

Authors:  Shubhra Acharya; Antonio Salgado-Somoza; Francesca Maria Stefanizzi; Andrew I Lumley; Lu Zhang; Enrico Glaab; Patrick May; Yvan Devaux
Journal:  Int J Mol Sci       Date:  2020-09-06       Impact factor: 5.923

Review 10.  Central Nervous System Cell-Derived Exosomes in Neurodegenerative Diseases.

Authors:  Yang Tian; Chen Fu; Yifan Wu; Yao Lu; Xuemei Liu; Yunling Zhang
Journal:  Oxid Med Cell Longev       Date:  2021-07-13       Impact factor: 6.543

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.